Skip to main content
Premium Trial:

Request an Annual Quote

The 'I Didn't See Your Citation' Excuse

Janet Stemwedel discusses the ongoing objections surrounding a Cell paper from last June by Jeffrey Axelrod's group that reported on a transmembrane protein that plays a large role as a signaling molecule in planar cell polarity in Drosophila. The objection is that another group, led by Peter Lawrence, had already done that work. In her post, Stemwedel focuses on citations, saying that building on the ideas and work of others is good when credit is properly given. "Should one do the research, publish the findings, and only after the fact discover that other scientists had been there first (and published about it), the sensible thing to do is to acknowledge those others late rather than not at all," she advises.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.